Original Research
Accepted on 17 Jul 2025
PNI as a predictive biomarker: a novel nomogram of immunotherapy efficacy in advanced breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1534545
Type at least 3 characters
1,443 articles
Original Research
Accepted on 16 Jul 2025
CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1625120
Original Research
Published on 16 Jul 2025
Lactylation-related gene signatures identify glioma molecular subtypes with prognostic, immunological, and therapeutic implications
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1613423
- 260 views
Mini Review
Published on 16 Jul 2025
Deciphering spatially confined immune evasion niches in osteosarcoma with 3-D spatial transcriptomics: a literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1640645
- 327 views
Study Protocol
Accepted on 15 Jul 2025
Total Neoadjuvant Chemoradiotherapy plus anti PD-1 for Mid-to-Low Locally Advanced Rectal Cancer: Study Protocol of a prospective, Single Arm, Phase Ⅱ Study (STARS -RC06)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1594927
- 133 views
Study Protocol
Accepted on 11 Jul 2025
Trial in progress: Phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1633324
- 197 views
Opinion
Published on 11 Jul 2025
Oncolytic virus VG161 offers new hope for refractory liver cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1605177
- 731 views
Mini Review
Published on 10 Jul 2025
Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1620501
- 445 views
Original Research
Published on 09 Jul 2025
Association of visceral obesity indicators with prostate cancer: a cross-sectional study from Xinjiang
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1614743
- 416 views
Original Research
Accepted on 08 Jul 2025
Association between emotional distress and the efficacy of advanced gastric cancer patients undergoing treatment with immune checkpoint inhibitors: A cohort study and propensity score matching study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1516643
Review
Published on 08 Jul 2025
Shaping viral immunotherapy towards cancer-targeted immunological cell death
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1540397
- 624 views
Original Research
Published on 08 Jul 2025
Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell lung cancer patients undergoing anti-PD1 therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1628379
- 294 views
Original Research
Accepted on 07 Jul 2025
Single-cell sequencing combined with machine learning to identify glioma biomarkers and therapeutic targets
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1629102
- 164 views
Original Research
Accepted on 07 Jul 2025
Identification and Comprehensive Analysis of An Immune-Related Gene Prognostic Model for Indicating Tumor Immune Microenvironment Features in Soft Tissue Sarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1609501
- 120 views
Original Research
Accepted on 30 Jun 2025
Performance of the neutrophil-to-lymphocyte ratio as a prognostic tool for survival in solid cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1616477
- 126 views
Original Research
Accepted on 30 Jun 2025
Multiplexed Immune Profiling and 3D Co-culture Assays to Assess the Individual Checkpoint Therapy Response in Head and Neck Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1622008